Clinical trial

Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018)

NCT06031246

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2023-04-01

PhasePHASE3

Study timeline

Study start (actual)2023-04-01Date precision: day

Registry last updated2023-09-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Adenocarcinomaunresolved

Lymph Node Metastasisunresolved

Interventions

Selective Lymph Node DissectionPROCEDURE

Sponsors & collaborators

Fudan Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06031246 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.